A review of uses of health care utilization databases for epidemiologic research on therapeutics

被引:954
作者
Schneeweiss, S
Avorn, J
机构
[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA
[2] Harvard Univ, Sch Med, Boston, MA 02120 USA
关键词
utilization databases; claims data; therapeuties; pharmaco-epidemiology; confounding (epidemiology); adverse drug reactions; drug utilization;
D O I
10.1016/j.jclinepi.2004.10.012
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: Large health care utilization databases are frequently used in variety of settings to study the use and outcomes of therapeutics. Their size allows the study of infrequent events, their representativeness of routine clinical care makes it possible to study real-world effectiveness and utilization patterns, and their availability at relatively low cost without long delays makes them accessible to many researchers. However, concerns about database studies include data validity, lack of detailed clinical information, and a limited ability to control confounding. Study Design and Setting: We consider the strengths, limitations, and appropriate applications of health care utilization databases in epidemiology and health services research, with particular reference to the study of medications. Conclusion: Progress has been made on many methodologic issues related to the use of health care utilization databases in recent years, but important areas persist and merit scrutiny. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:323 / 337
页数:15
相关论文
共 117 条
[61]   Econometrics in outcomes research: The use of instrumental variables [J].
Newhouse, JP ;
McClellan, M .
ANNUAL REVIEW OF PUBLIC HEALTH, 1998, 19 :17-34
[62]   A simulation study of the number of events per variable in logistic regression analysis [J].
Peduzzi, P ;
Concato, J ;
Kemper, E ;
Holford, TR ;
Feinstein, AR .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (12) :1373-1379
[63]   Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics [J].
Platt, R ;
Davis, R ;
Finkelstein, J ;
Go, AS ;
Gurwitz, JH ;
Roblin, D ;
Soumerai, S ;
Ross-Degnan, D ;
Andrade, S ;
Goodman, MJ ;
Martinson, B ;
Raebel, MA ;
Smith, D ;
Ulcickas-Yood, M ;
Chan, KA .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2001, 10 (05) :373-377
[64]   Assessment and control for confounding by indication in observational studies [J].
Psaty, BM ;
Koepsell, TD ;
Lin, DY ;
Weiss, NS ;
Siscovick, DS ;
Rosendaal, FR ;
Pahor, M ;
Furberg, CD .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (06) :749-754
[65]   Assessing accuracy of diagnosis-type indicators for flagging complications in administrative data [J].
Quan, H ;
Parsons, GA ;
Ghali, WA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2004, 57 (04) :366-372
[66]   Policy and program analysis using administrative databases [J].
Ray, WA .
ANNALS OF INTERNAL MEDICINE, 1997, 127 (08) :712-718
[67]   Evaluating medication effects outside of clinical trials: New-user designs [J].
Ray, WA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 158 (09) :915-920
[68]   Non-steroidal anti-inflamatory drugs and risk of serious coronary heart disease: an observational cohort study [J].
Ray, WA ;
Stein, CM ;
Hall, K ;
Daugherty, JR ;
Griffin, MR .
LANCET, 2002, 359 (9301) :118-123
[69]   Use and misuse of population attributable fractions [J].
Rockhill, B ;
Newman, B ;
Weinberg, C .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1998, 88 (01) :15-19
[70]   The role of databases in drug postmarketing surveillance [J].
Rodriguez, EM ;
Staffa, JA ;
Graham, DJ .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2001, 10 (05) :407-410